A Trial of Neoadjuvant Chemotherapy for Stage II, III Esophageal Squamous Cell Carcinoma

NCT02915965 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Stage II and III Esophageal Squamous Cell Carcinoma

Interventions

DRUG: DCX
PROCEDURE: surgery

Sponsor

Sun Yat-sen University